- Trials with a EudraCT protocol (389)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
389 result(s) found for: Cortisol.
Displaying page 1 of 20.
EudraCT Number: 2009-014909-14 | Sponsor Protocol Number: CS/München01 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Max-Planck-Institut für Psychiatrie | |||||||||||||
Full Title: Neuropsychological effects of hydrocortisone substitution in patients with partial adrenal insufficiency after traumatic brain injury or subarachnoidal haemorrhage | |||||||||||||
Medical condition: hormonal deficiency after traumatic-brain- injury (TBI) or subarachnoidal haemorrhage (SAH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001104-37 | Sponsor Protocol Number: ME/2011/3709 | Start Date*: 2014-10-06 | ||||||||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | ||||||||||||||||||
Full Title: Pulsed glucocorticoid replacement therapy for patients with adrenocortical insufficiency secondary to Addison’s disease and congenital adrenal hyperplasia | ||||||||||||||||||
Medical condition: Addison's disease and Congenital Adrenal Hyperplasia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001437-12 | Sponsor Protocol Number: Ex17 | Start Date*: 2017-06-12 |
Sponsor Name:University of Tartu | ||
Full Title: Effect of exenatide on cortisol secretion | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: EE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005640-14 | Sponsor Protocol Number: 42994 | Start Date*: 2013-04-15 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: The effects of hormonal contraception on the HPA-axis functioning | |||||||||||||
Medical condition: healthy female volunteers; hormonal contraception method used: combined method (oestrogens en progestins) and progesterone-only method. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000161-40 | Sponsor Protocol Number: AdrenalClock | Start Date*: 2022-07-18 |
Sponsor Name:Medical University of Vienna, Division of Endocrinology | ||
Full Title: Investigating cardiometabolic risk factors and changes in chronobiology patterns in patients with autonomous adrenal cortisol secretion | ||
Medical condition: Autonomous cortisol secretion in patients with adrenal adenoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002241-18 | Sponsor Protocol Number: 983.974.742 | Start Date*: 2023-03-14 |
Sponsor Name:Helse Bergen HF | ||
Full Title: Diagnostic treatment-trial for autonomous cortisol secretion- a tool to select patients for adrenalectomy | ||
Medical condition: autonomous cortisol secretion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003367-40 | Sponsor Protocol Number: 2007/049/HP | Start Date*: 2009-03-03 |
Sponsor Name:CHU de Rouen | ||
Full Title: Pilot study of the effect of a substance P antagonist, aprepitant, on aldosterone and cortisol secretions in healthy volunteers | ||
Medical condition: The aim is to measure plasma aldosterone and cortisol concentrations in basal conditions and in response to different stimulation tests of the adrenal function | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000864-82 | Sponsor Protocol Number: hydrocortisone | Start Date*: 2011-12-22 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: A randomized double blind cross-over study of the effects of low dose and high dose hydrocortisone replacement therapy on cognition, quality of life, metabolic profile and somatosensation in patien... | |||||||||||||
Medical condition: Secondary adrenal insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004189-33 | Sponsor Protocol Number: REK322442 | Start Date*: 2013-11-28 |
Sponsor Name:Haukeland University Hospital | ||
Full Title: ULTRADIAN SUBCUTANEOUS HYDROCORTISONE (USHI) INFUSION IN ADDISON’S DISEASE | ||
Medical condition: Addison`s disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004764-31 | Sponsor Protocol Number: 02-2006 | Start Date*: 2007-01-11 |
Sponsor Name:Max Planck Institute of Psychiatry | ||
Full Title: Effects of corticotropin-releasing hormone on sleep electroencephalogram and sleep associated hormone secretion in young healthy women | ||
Medical condition: Healthy volunteers. The aim is to test the effects of CRH on sleep electroencephalogram and sleep associated secretion of growth hormone and cortisol | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003913-15 | Sponsor Protocol Number: ANTRAG01 | Start Date*: Information not available in EudraCT |
Sponsor Name:Medical University Innsbruck | ||
Full Title: Wirkung von Oxcarbazepin (Trileptal) auf den Kortikosteroid-Metabolismus - Pilotstudie | ||
Medical condition: Oxcarbazepin, a widely-used antiepileptic treatment is evaluated with respect to Cortisol-degradation. Young adults and adults with oxcarbazepine monotherapy since at least 6 months and temporal lo... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005605-93 | Sponsor Protocol Number: SILYCUS-21 | Start Date*: 2021-12-21 | |||||||||||
Sponsor Name:ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.P.A. | |||||||||||||
Full Title: Efficacy and safety of Silycus® in Cushing’s disease: a multicenter, single arm, open label, dose titration, proof of concept study (Silycus®-21) | |||||||||||||
Medical condition: Cushing's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003331-10 | Sponsor Protocol Number: HC03 | Start Date*: 2017-10-16 |
Sponsor Name:Leiden University | ||
Full Title: Acute effects of 40 mg cortisol on emotion and cognition. | ||
Medical condition: None. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000899-23 | Sponsor Protocol Number: CORT125134-451 | Start Date*: 2016-08-16 | |||||||||||
Sponsor Name:Corcept Therapeutics Incorporated | |||||||||||||
Full Title: Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing’s Syndrome | |||||||||||||
Medical condition: Endogenous Cushing’s Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001768-30 | Sponsor Protocol Number: HYSS 3 | Start Date*: 2006-01-04 |
Sponsor Name:EM-kliniken | ||
Full Title: Comparison of 2 and 4 doses hydrocortison substitution with regard to plasma concentration and quality of life. | ||
Medical condition: We aim to study patients with cortisol deficiency caused by primary adrenal insufficiency (Addison’s disease of autoimmune origin). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006379-65 | Sponsor Protocol Number: 02A801 | Start Date*: 2008-10-27 |
Sponsor Name:ISTITUTO AUXOLOGICO ITALIANO | ||
Full Title: Evaluation of the benefit-risk profile of retinoic acid in the treatment of Cushing`s disease | ||
Medical condition: sperimentation only in patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001090-40 | Sponsor Protocol Number: ATC017HC | Start Date*: 2015-06-22 | |||||||||||
Sponsor Name:The London Clinic | |||||||||||||
Full Title: An open label pilot study to investigate the effects of two preparations of hydrocortisone (Hydrocortisone 100mg/ml and Solu-Cortef) injected intramuscularly into the deltoid and upper thigh muscle... | |||||||||||||
Medical condition: Addison's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018720-12 | Sponsor Protocol Number: pb01 | Start Date*: 2010-04-22 |
Sponsor Name:Swedish Pituitary Study group | ||
Full Title: Behandling med kabergolin hos patienter med ACTH-beroende Cushing´s syndrom (treatment with cabergoline in patients with ACTH-dependent Cushing´s syndrome | ||
Medical condition: A) Men and women aged 18 to 75 years with hypercortisolism due to ACTH-dependent Cushing's syndrome will be treated in the period between diagnosis and planned surgery or radiation therapy. B) Men... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002063-26 | Sponsor Protocol Number: METYX01 | Start Date*: 2013-09-08 |
Sponsor Name:S.C.D.U. MEDICINA INTERNA 1 Ospedale San Luigi Orbassano | ||
Full Title: A prospective open-label Phase 2 study of METYRAPONE as a preoperative treatment in patients with ACTH-independent Cushing’s syndrome due to adrenal adenoma. | ||
Medical condition: Cushing's syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003627-20 | Sponsor Protocol Number: NAI008/I | Start Date*: 2009-01-28 |
Sponsor Name:University of Dundee, Research & Innovation Services | ||
Full Title: Comparative Relative Lung Bioavailability of HFA-Seretide via spacer devices in healthy volunteers | ||
Medical condition: Bronchial Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.